The relationship between lipodystrophy-associated body changes and measures of quality of life and mental health for HIV-positive adults

Quality of Life Research

Volumn 14, Issue 4, 2005, Pages 981-990

  Burgoyne, Robert ^a,b   Collins, Evan ^a,b   Wagner, Cheryl ^c   Abbey, Susan ^a,b   Halman, Mark ^b,d   Nur, Margaret ^a   Walmsley, Sharon ^a,e  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HIV Primary Care Physician   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Body image; HIV; Lipodystrophy; Mental health; Quality of life

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; ATROPHY; BODY FAT; BODY IMAGE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EVALUATION; FEMALE; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTROPHY; LIPODYSTROPHY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MENTAL HEALTH; PATIENT; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SOCIAL PSYCHOLOGY; SYMPTOM; WELLBEING;

ADULT; BODY IMAGE; FEMALE; HIV SEROPOSITIVITY; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; MIDDLE AGED; ONTARIO; QUALITY OF LIFE; SICKNESS IMPACT PROFILE;

EID: 18844408365     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-004-2580-2     Document Type: Article

References (38)

1. X Badia D Podzamczer M Garcia C Lopez-David E. Consiglio 1999 A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients AIDS 13 1727 1735
2. R Burgoyne R. Renwick 2004 Social support and quality of life over time among adults living with HIV in the HAART era Soc Sci Med 58 1353 1366
3. R Burgoyne D. Saunders 2001 Quality of life among urban Canadian HIV/AIDS clinic outpatients Int J STD AIDS 12 505 512
4. P Carrieri B Spire S Duran C Katlama D Peyramond C Francois 2003 Health-related quality of life after 1 year of highly active antiretroviral therapy J Acquir Immune Defic Syndr 32 38 47
5. W Cunningham M Shapiro R Hays W Dixon B Visscher L George 1998 Constitutional symptoms and health-related'quality of life in patients with symptomatic HIV disease Am J Med 104 129 136
6. R Murri A Ammassari M Fantoni G. Scoppettuolo 1997 Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV health survey J AIDS Hum Retrovirol 16 350 356
7. D Saunders R. Burgoyne 2002 Evaluating health-related wellbeing outcomes among outpatient adults with human immunodeficiency virus infection in the HAART era Int J STD AIDS 13 683 690
8. D Vogl B Rosenfeld W Breitbart H Thaler S Passik M McDonald 1999 Symptom prevalence, characteristics, and distress in AIDS outpatients J Pain Symptom Manage 18 253 262
9. T Wachtel J Piette V Mor M Stein J Fleishman C. Carpenter 1992 Quality of life in persons with human immunodeficiency virus infection: Measurement by the medical outcomes study instrument Ann Intern Med 116 129 137
10. A Wu H Rubin W Mathews J Ware L Brysk W Hardy 1991 A health status questionnaire using 30 items from the medical outcomes study Med Care 29 786 798
11. A Carr K Samaras A Thorisdottir G Kaufmann D Chisholm D. Cooper 1999 Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia and diabetes mellitus: A cohort study Lancet 353 2093 2099
12. K Heath R Hogg K Chan M Harris V Montessori M O'Shaugnessy 2001 Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database AIDS 15 231 239
13. M Schambelan C Benson A Carr J Currier M Dube J Gerber 2002 Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: Recommendations of an International AIDS Society-USA panel J AIDS 31 257 275
14. R Hogg K Heath B Yip K Craib M O'Shaughnessy M Schecter 1998 Improved survival among HIV-infected individuals following initiation of antiviral therapy JAMA 279 450 454
15. F Palella K Delaney A Moorman M Loveless J Fuhrer G Satten 1998 Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection N Engl J Med 338 853 860
16. S Bassetti M Battegay H Furrer M Rickenback M Flepp L Kaiser 1999 Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? J AIDS 21 114 119
17. R Shafer D. Vuitton 1999 Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1 Biomed Pharmacother 53 73 86
18. E Collins C Wagner S. Walmsley 2000 Psychosocial impact of the lipodystrophy syndrome in HIV infection AIDS Reader 10 546 550
19. H Dukers I Stolte N Albrecht R Coultinho J de Wit 2001 The impact of experiencing lipodystrophy on the sexual behaviour and well-being among HIV-infected homosexual men [Letter] AIDS 15 812 813
20. M Oette P Juretzko A Kroidl A Sagir M Wettstein J Siegrist 2002 Lipodystrophy syndrome and self-assessment of well-being and physical appearance in HIV-positive patients AIDS Patient Care 16 413 417
21. N Paton A Earnest Y Ng F Karim J. Aboulhab 2002 Lipodystrophy in a cohort of human immunodeficiency virus-infected Asian patients: Prevalence, associated factors and psychological impact Clin Infect Dis 35 1244 1249
22. R Power H Tate S McGill C. Taylor 2003 A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals Sex Transm Infect 79 137 141
23. L Lenert M Feddersen A Sturley D. Lee 2002 Adverse effects of medications and trade-offs between length of life and quality of life in human immunodeficiency virus infection Am J Med 113 229 232
24. J Blanch A Rousaud E Martinez E De Lazzari J Peri A Milinkovic 2002 Impact of lipodystrophy on the quality of life of HIV-1-infected patients J Acquir Immune Defic Syndr 31 404 407
25. A Carr K Samaras S Burton J Freund D Chisholm D. Cooper 1998 A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors AIDS 12 F51 F58
26. A Justice L Rabeneck R Hays A Wu S. Bozzette 1999 Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: A comparison with self-reported symptoms J AIDS 21 126 133
27. A Wu D Revicki D Jacobson F. Malitz 1997 Evidence for reliability, validity and usefulness of the Medical Outcome Study HIV Health Survey (MOS-HIV) Qual Life Res 6 481 493
28. W Holmes J. Shea 1998 A new HIV/AIDS-targeted quality of life (HAT-QOL) instrument: Development, reliability and validity Med Care 36 138 154
29. P Ganz C Schag B Kahn L Petersen K. Hirji 1993 Describing the health-related quality of life impact of HIV infection: Findings from a study using the HIV Overview of Problems-Evaluation System (HOPES) Qual Life Res 2 109 119
30. E Martinez M Garcia-Viejo J Blanch J Gatell 2001 Lipodystrophy syndrome in patients with HIV infection: Quality of life issues Drug Safety 24 157 166
31. L Derogatis N. Melisaratos 1979 The DSFI: A multidimensional measure of sexual functioning J Sex Marital Ther 5 244 281
32. C Spielberger R Gorsuch R Lushene P Vagg G. Jacobs 1983 State-Trait Anxiety Inventory for Adults Mind Garden Inc. Palo Alto CA
33. M. Rosenberg 1965 Society and the Adolescent Self-Image Princeton University Press Princeton NJ
34. nd edition, San Antonio, TX: The Psychological Corporation (Harcourt Brace & Co.), 1996.
35. L. Chapman 1998 Body image and HIV: Implications for support and care AIDS Care. 10 S179 S189
36. R Burgoyne S Rourke D Behrens I. Salit 2004 Long-term quality of life outcomes among adults living with HIV in the HAART era: The interplay of changes in clinical factors and symptom profile AIDS Behav 8 151 163
37. A Fontaine F Larue J. Lassauniere 1999 Physicians' recognition of the symptoms experienced by HIV patients: How reliable? J Pain Symptom Manage 18 263 270
38. A Justice C Chang L Rabeneck R. Zackin 2001 Clinical importance of provider-reported HIV symptoms compared with patient-report Med Care 39 397 408